Distribution, clinical features and molecular analysis of primary immunodeficiency diseases in chinese children: A single-center study from 2005 to 2011

Pediatric Infectious Disease Journal

Volumn 32, Issue 10, 2013, Pages 1127-1134

  Zhang, Zhi Yong ^a   An, Yun Fei ^a   Jiang, Li Ping ^a   Liu, Wei ^a   Liu, Da Wei ^a   Xie, Jing Wen ^a   Tang, Xue Mei ^a   Wang, Mo ^a   Yang, Xi Qiang ^a   Zhao, Xiao Dong ^a  

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

China; Clinical feature; Epidemiology; Molecular analysis; Primary immunodeficiency diseases

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN;

ARTICLE; CHILD; CHINA; CHINESE; CHRONIC GRANULOMATOUS DISEASE; CLINICAL COMPETENCE; CLINICAL FEATURE; COMPETENCE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; INFANT; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; MOLECULAR PATHOLOGY; NEWBORN; PHAGOCYTE; PRESCHOOL CHILD; PRIMARY IMMUNODEFICIENCY DISEASE; PRIORITY JOURNAL; SCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; CHINA; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; MALE; RETROSPECTIVE STUDIES;

EID: 84891825946     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31829aa9e9     Document Type: Article

References (44)

1. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93: 190-197.
2. Bonilla FA, Geha RS. Primary immunodeficiency diseases. J Clin Immunol. 2003;111: 571-581.
3. Al-Herz W, Bousfiha A, Casanova JL, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2011;2: 54.
4. Lee WI, Huang JL, Jaing TH, et al. Distribution, clinical features and treatment in Taiwanese patients with symptomatic primary immunodeficiency diseases (PIDs) in a nationwide population-based study during 1985-2010. Immunobiology. 2011;216: 1286-1294.
5. Grumach AS, Duarte AJ, Bellinati-Pires R, et al. Brazilian report on primary immunodeficiencies in children: 166 cases studied over a follow-up time of 15 years. J Clin Immunol. 1997;17: 340-345.
6. Joshi AY, Iyer VN, Hagan JB, et al. Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clin Proc. 2009;84: 16-22.
7. Matamoros Florí N, Mila Llambi J, Español Boren T, et al. Primary immunodeficiency syndrome in Spain: first report of the National Registry in Children and Adults. J Clin Immunol. 1997;17: 333-339.
8. Abuzakouk M, Feighery C. Primary immunodeficiency disorders in the Republic of Ireland: first report of the national registry in children and adults. J Clin Immunol. 2005;25: 73-77.
9. Baumgart KW, Britton WJ, Kemp A, et al. The spectrum of primary immunodeficiency disorders in Australia. J Allergy Clin Immunol. 1997;100: 415-423.
10. Al-Herz W. Primary immunodeficiency disorders in Kuwait: first report from Kuwait national primary immunodeficiency registry. J Clin Immunol. 2008;28: 186-193.
11. Zhang ZY, Xiao HQ, Jiang LP, et al. Analysis of clinical and molecular characteristics of Wiskott-Aldrich syndrome in 24 patients from 23 unrelated Chinese families. Pediatr Allergy Immunol. 2010;21: 522-532.
12. Zhang ZY, Zhao XD, Jiang LP, et al. Clinical characteristics and molecular analysis of 21 Chinese children with congenital agammaglobulinemia. Scand J Immunol. 2010;72: 454-459.
13. Zhang ZY, Zhao XD, Jiang LP, et al. Clinical characteristics and molecular analysis of 3 chinese children with Omenn syndrome. Pediatric Allergy Immunol. 2011;22: 482-487.
14. An YF, Xu F, Wang M, et al. Clinical and molecular characteristics of immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in China. Scand J Immunol. 2011;74: 304-309.
15. An Y, Xiao J, Jiang L, et al. Clinical and molecular characterization of X-linked hyper-IgM syndrome patients in China. Scand J Immunol. 2010;72: 50-56.
16. Gathmann B, Binder N, Ehl S, et al. The European internet-based patient and research database for primary immunodeficiencies:update 2011. Clin Exp Immunol. 2012;167: 479-491.
17. Leiva LE, Zelazco M, Oleastro M, et al.; Latin American Group for Primary Immunodeficiency Diseases. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol. 2007;27: 101-108.
18. Lee WI, Kuo ML, Huang JL, et al. Distribution and clinical aspects of primary immunodeficiencies in a Taiwan pediatric tertiary hospital during a 20-year period. J Clin Immunol. 2005;25: 162-173.
19. Eades-Perner AM, Gathmann B, Knerr V, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol. 2007;147: 306-312.
20. Alsum Z, Hawwari A, Alsmadi O, et al. Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients. J Clin Immunol. 2013;33: 55-67.
21. Minegishi Y. Hyper-IgE syndrome. Curr Opin Immunol. 2009;21: 487-492.
22. Heimall J, Freeman A, Holland SM. Pathogenesis of hyper IgE syndrome. Clin Rev Allergy Immunol. 2010;38: 32-38.
23. Sowerwine KJ, Holland SM, Freeman AF. Hyper-IgE syndrome update. Ann N Y Acad Sci. 2012;1250: 25-32.
24. Ryser O, Morell A, Hitzig WH. Primary immunodeficiencies in Switzerland: first report of the national registry in adults and children. J Clin Immunol. 1988;8: 479-485.
25. Stray-Pedersen A, Abrahamsen TG, Frøland SS. Primary immunodeficiency diseases in Norway. J Clin Immunol. 2000;20: 477-485.
26. Rezaei N, Aghamohammadi A, Moin M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol. 2006;26: 519-532.
27. Mila LIambi J, Etxagibel Galdos A, Matamoros Flori N. The Spanish Registry of Primay Immunodeficiencies (REDIP). Allergol Immunopathol. 2001;29: 122-125.
28. Takahashi N, Morio T. Common variable immunodeficiency. Nihon Rinsho Meneki Gakkai Kaishi. 2008;31: 9-16.
29. Lee JJ, Ozcan E, Rauter I, et al. Transmembrane activator and calciummodulator and cyclophilin ligand interactor mutations in common variable immunodeficiency. Curr Opin Allergy Clin Immunol. 2008;8: 520-526.
30. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92: 34-48.
31. Woroniecka M, Ballow M. Office evaluation of children with recurrent infection. Pediatr Clin North Am. 2000;47: 1211-1224.
32. Buckley RH. Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med. 2000;343: 1313-1324.
33. Lee PP, Chen TX, Jiang LP, et al. Clinical characteristics and genotypephenotype correlation in 62 patients with X-linked agammaglobulinemia. J Clin Immunol. 2010;30: 121-131.
34. Ballow M. Primary immunodeficiency disorders: antibody deficiency. J Allergy Clin Immunol. 2002;109: 581-591.
35. Elder ME. T-cell immunodeficiencies. Pediatr Clin North Am. 2000;47: 1253-1274.
36. Quartier P, Debré M, De Blic J, et al. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr. 1999;134: 589-596.
37. Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol. 2002;109: 1001-1004.
38. Conley ME, Howard V. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia. J Pediatr. 2002;141: 566-571.
39. Grumach AS, Duarte AJ, Bellinati-Pires R, et al. Brazilian report on primary immunodeficiencies in children: 166 cases studied over a follow-up time of 15 years. J Clin Immunol. 1997;17: 340-345.
40. Buckley RH. Primary cellular immunodeficiencies. J Allergy Clin Immunol. 2002;109: 747-757.
41. Ariga T, Kondoh T, Yamaguchi K, et al. Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome. J Immunol. 2001;166: 5245-5249.
42. Wada T, Konno A, Schurman SH, et al. Second-site mutation in the Wiskott- Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings. J Clin Invest. 2003;111: 1389-1397.
43. Wada T, Schurman SH, Otsu M, et al. Somatic mosaicism in Wiskott- Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism. Proc Natl Acad Sci U S A. 2001;98: 8697-8702.
44. Ariga T, Yamada M, Sakiyama Y, et al. A case of Wiskott-Aldrich syndrome with dual mutations in exon 10 of the WASP gene: an additional de novo one-base insertion, which restores frame shift due to an inherent one-base deletion, detected in the major population of the patient's peripheral blood lymphocytes. Blood. 1998;92: 699-701.